vialaudit
The Roundup
semaglutide · maine

Is Semaglutide legal in Maine?

status · no specific restrictions
FDA-approved GLP-1 receptor agonist (Ozempic/Wegovy/Rybelsus); shortage resolved Feb 2025; compounded copies broadly restricted; FDA Warning Letters target salt-form variants and counterfeit sema. No state-level peptide restrictions beyond federal law in Maine.

category: fda approved · last verified May 13, 2026

§ 01

Quick answer

FDA-approved GLP-1 receptor agonist (Ozempic/Wegovy/Rybelsus); shortage resolved Feb 2025; compounded copies broadly restricted; FDA Warning Letters target salt-form variants and counterfeit sema. No state-level peptide restrictions beyond federal law in Maine.
§ 02

Full status breakdown

Federal status

FDA approval
approved as drug · brand: Ozempic, Wegovy, Rybelsus · NDA 209637 (Ozempic); NDA 213051 (Rybelsus); NDA 215256 (Wegovy) · approved Dec 5, 2017
Indications: T2DM; chronic weight management; CV risk reduction; MASH
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Approved drug; post-shortage compounding of essentially-copies restricted under §503A. 503A enforcement discretion ended Apr 22, 2025; 503B May 22, 2025. FDA proposed April 2026 exclusion from 503B bulks list.
FDA Warning Letters
  • Feb 7, 2024 — US Chem Labs (cited: semaglutide) · letter ↗
  • Sep 9, 2025 — SemaBio (cited: semaglutide) · letter ↗
  • Sep 9, 2025 — Hims & Hers (Hers) (cited: semaglutide) · letter ↗
  • Feb 20, 2026 — Better Health Labs dba Measured (cited: semaglutide) · letter ↗
Shortage status
not currently on shortage list
Historical shortage window: Jan 1, 2022 → Feb 21, 2025
Sale framing
Research-use-only posture: RUO does not protect sellers when site evidence shows human-use intent. FDA has flagged salt-form variants of compounded semaglutide as distinct from the approved drug.
Personal possession: Not federally controlled; personal possession is not a federal crime. Approved sema is Rx-only and dispensing without prescription violates federal and state pharmacy law.

Maine — state-specific

Sport-body status

WADA 2026
on prohibited list · class S2 · both
S2 (Peptide hormones); GLP-1 receptor agonist captured by class language.
USADA
NCAA

What we couldn’t verify

§ 03

Also known as

Semaglutide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Ozempic
  • Wegovy
  • Rybelsus
  • Sema
  • Sema-1
  • GLP-1 receptor agonist
  • NDA 209637
  • NDA 213051
  • NDA 215256
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch